Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

about

Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia.

P2860

Q47915074-67A40838-FAD8-4D91-AB66-B91D0408187B

P2860

Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

Item

http://www.wikidata.org/entity/Q40799248

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

@en

type

Item

label

Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

@en

prefLabel

Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

@en

P1476

Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

@en

P2093

Auryan Szalat

http://www.w3.org/2001/XMLSchema#string

Christian Rosenberger

http://www.w3.org/2001/XMLSchema#string

Mogher Khamaisi

http://www.w3.org/2001/XMLSchema#string

Samuel N Heyman

http://www.w3.org/2001/XMLSchema#string

Zaid Abassi

http://www.w3.org/2001/XMLSchema#string

P2860

Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys

Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension.

Regulation of erythropoiesis by hypoxia-inducible factors

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.

Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats.

Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization.

Adaptation to hypoxia in the diabetic rat kidney.

P304

176-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/JOCMR2849W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28090234

http://www.w3.org/2001/XMLSchema#string

P921

glucose

glycobiology

P932

5215022

http://www.w3.org/2001/XMLSchema#string

Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

about

P2860

P2860

Increased Hematocrit During Sodium-Glucose Cotransporter-2 Inhibitor Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932